Clinical Trial Update: The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether a single dose of D-Cycloserine improves cognitive outcomes in adults with moderate traumatic brain injury. The do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Traumatic Brain Injury | Phase 2 | Status: UNKNOWN